38th week of 2009 patent applcation highlights part 40 |
Patent application number | Title | Published |
20090233953 | ANTAGONISTS OF THE VANILLOID RECEPTOR SUBTYPE 1 (VR1) AND USES THEREOF - The present invention is directed to compounds of formula (I) | 2009-09-17 |
20090233989 | Oligonucleotides stimulatory of the mesenchymal stem cell proliferation and uses thereof - Oligonucleotides having the ability to greatly stimulate the proliferation of pluripotent mesenchymal stem cells “in vitro” and “in vivo” of animals, including humans, are disclosed. These oligonucleotides can be used in a wide range of clinical procedures such as (1) regeneration of mesenchymal tissues which have been damaged through acute injury, abnormal genetic expression or acquired disease by inoculation of the ODNs of this invention; (2) treatment of a host with damaged mesenchymal tissue by removal of small aliquots of bone marrow, isolation of their mesenchymal stem cells and treatment of the damaged tissue with MSCs culture-expanded by incubation with one or more of the ODNs of this invention combined with a biocompatible carrier suitable for delivering the MSCs to the damaged body site(s); (3) production “in vitro” of various mesenchymal tissues by directed differentiation of the MSCs culture-expanded by incubation with one or more of the ODNs of this invention, to replace and restore tissue damage or defects with say “in vitro” obtained mesenchymal tissues combined with a biocompatible carrier suitable for delivering the “in vitro” produced tissues to the damaged body site(s); and (4) treatment of a host with abnormal genetic expression with MSCs culture-expanded by incubation with one or more of the ODNs of this invention and transformed by genetic engineering procedures to express a protein able to replace the genetic deffect. | 2009-09-17 |
20090233990 | GENERATION OF BIOLOGICAL PACEMAKER ACTIVITY - Compositions and methods for enhancing hyperpolarization-activated cation inward current and disrupting inwardly rectifying potassium current of cells are described. The compositions and methods may be employed to cause the cells to become biological pacemaker cells, e.g. to become more like SA node cells, and to undergo spontaneous oscillating action potentials. | 2009-09-17 |
20090233991 | GENERATION OF BIOLOGICAL PACEMAKER ACTIVITY - Compositions and methods for enhancing hyperpolarization-activated cation inward current and disrupting inwardly rectifying potassium current of cells are described. The compositions and methods may be employed to cause the cells to become biological pacemaker cells, e.g. to become more like SA node cells, and to undergo spontaneous oscillating action potentials. | 2009-09-17 |
20090233992 | HEPATITIS C VIRUS VACCINE - The present invention features Ad6 vectors and a nucleic acid encoding a Met-NS3-NS4A-NS4B-NS5A-NS5B polypeptide containing an inactive NS5B RNA-dependent RNA polymerase region. The nucleic acid is particularly useful as a component of an adenovector or DNA plasmid vaccine providing a broad range of antigens for generating an HCV specific cell mediated immune (CMI) response against HCV. | 2009-09-17 |
20090233993 | COMPOSITIONS AND METHODS FOR INHIBITING GSK3 ACTIVITY AND USES THEREOF - Disclosed herein are compositions and methods relating to peptides. The peptides can inhibit amyloid beta (Aβ) generation and reduce GSK-3 activities. Further provided are compositions and methods for treating or preventing, for example, Alzheimer's disease, cancer, and diabetes. | 2009-09-17 |
20090233994 | Novel Glutamic Acid Decarboxylase (GAD) Chimera And Methods Of Use - The invention relates to a novel Glutamic Acid Decarboxylase (GAD). More specifically, novel DNA and protein sequences relating to GAD. Additionally, the invention discloses a novel composition and related methods for treating neurodegenerative diseases such as Parkinson's disease, Alzheimer's disease, epilepsy, and the like, using viral and non-viral delivery systems that deliver therapeutic agents to specific regions of the brain. More specifically, using an adeno-associated viral vector to deliver a nucleotide sequence encoding a novel glutamic acid decarboxylase (GAD) to specific regions of the brain that are over stimulated or disinhibited in various diseases, including neurodegenerative diseases | 2009-09-17 |
20090233995 | Use of drug combinations for treating insulin resistance - The present invention provides pharmaceutical compositions comprising: (a) a modulator of hepatic parasympathetic tone, (b) at least one diabetes drug, and (c) a pharmaceutically acceptable carrier. The present invention includes methods for the treatment and/or prevention of insulin resistance, type 2 diabetes, impaired glucose intolerance, and other associated disorders with pharmaceutical compositions described herein. The invention also provides for a kit comprising a pharmaceutical composition and instructions for its use. | 2009-09-17 |
20090233996 | AVERMECTIN/BENZOYL PEROXIDE COMPOSITIONS FOR TREATING AFFLICTIONS OF THE SKIN, E.G., ROSACEA - Pharmaceutical/dermatological compositions containing at least one avermectin compound, e.g., ivermectin and benzoyl peroxide, are useful for treating afflictions of the skin, especially rosacea. | 2009-09-17 |
20090233997 | COMPOSITION FOR PROMOTING SYNTHESIS OF COLLAGEN, AND COMPOSITION FOR EXTERNAL PREPARATION FOR SKIN COMPRISING THE SAME - The present invention relates to a composition for promoting collagen synthesis and a composition for external application to skin which includes the collagen synthesis promoting composition. The collagen synthesis promoting composition includes, as an effective component, at least one selected from the group consisting of compounds represented as: wherein R is hydrogen, a methoxy group, or a 3-methyl-2-butenyl group. The composition for external application to skin includes at least one collagen synthesis promoting component selected from the group consisting of compounds represented by above. | 2009-09-17 |
20090234003 | CARBAMATE COMPOUNDS FOR USE IN PREVENTING OR TREATING ANXIETY DISORDERS - This invention is directed to a method for preventing or treating anxiety disorders comprising administering to a subject in need thereof a therapeutically effective amount of a compound selected from the group consisting of Formula (I) and Formula (II): | 2009-09-17 |
20090234008 | Method of using catalpic acid to treat and prevent dyslipidemia, type 2 diabetes, and associated disorders - A method of treating and preventing dyslipidemia, cardiovascular disease, type 2 diabetes, obesity and other diseases associated with the Metabolic Syndrome and of increasing the expression of genes that promote lipid oxidation in an animal, including mammals and humans, in which a therapeutically effective amount of catalpic acid is administered orally or parenterally to the animal. | 2009-09-17 |
20090234009 | Kallikrein Inhibitors and Anti-Thrombolytic Agents and Uses Thereof - Methods, kits and compositions are described that include a non-naturally occurring kallikrein inhibitor and an anti-thrombolytic agent, e.g., an anti-fibrinolytic agent, for preventing or reducing blood loss and/or ischemia, e.g., ischemia associated with perioperative blood loss and cerebral ischemia, the onset of systemic inflammatory response, and/or reperfusion injury, e.g., reperfusion injury associated with cerebral ischemia or a focal brain ischemia, e.g., in patients subjected to invasive surgical procedures, especially procedures requiring cardiopulmonary bypass. | 2009-09-17 |
20090234010 | MANUFACTURE PROCESS OF ORGANIC COMPOUNDS - The present invention relates to a method of preparing N-substituted salicylamides or derivatives thereof and their derivatives, e.g. their salts. In particular, the present invention relates to a method of preparing (N-(5-chlorosalicyloyl)-8-aminocaprylic acid (5-CNAC) and its corresponding disodium monohydrate. | 2009-09-17 |
20090234011 | N-ACETYLCYSTEINE AMIDE (NAC AMIDE) FOR THE TREATMENT OF DISEASES AND CONDITIONS ASSOCIATED WITH OXIDATIVE STRESS - Methods and compositions comprising N-acetylcysteine amide (NAC amide) and derivatives thereof are used in treatments and therapies for human and non-human mammalian diseases, disorders, conditions and pathologies. Pharmaceutically or physiologically acceptable compositions of NAC amide or derivatives thereof are administered alone, or in combination with other suitable agents, to reduce, prevent, or counteract oxidative stress and free radical oxidant formation and overproduction in cells and tissues, as well as to provide a new source of glutathione. | 2009-09-17 |
20090234012 | ADMINISTRATION OF DOPA PRECURSORS WITH SOURCES OF DOPA TO EFFECTUATE OPTIMAL CATECHOLAMINE NEUROTRANSMITTER OUTCOMES - A method of treating neurotransmitter dysfunction in a patient by optimizing catecholamine levels by administration of L-3,4-dihydroxyphenylalanine (L-Dopa or Dopa) precursors in combination with a source of L-Dopa. The dopa precursor is preferably administered in such quantities such that the amount of dopa from the dopa precursors does not fluctuate and affect outcomes in the synthesis of dopamine from dopa administration. The dopa precursor source is preferably tyrosine, but may alternatively be phenylalanine, N-acetyl-tyrosine, any active isomer thereof, or any other dopa precursor. The source of L-Dopa may include any natural or synthetic source, including, but not limited to, Mucuna pruriens. | 2009-09-17 |
20090234013 | PHARMACEUTICAL COMPOSITIONS HAVING DESIRABLE BIOAVAILABILITY - The present invention is directed to the provision of pharmaceutical compositions. The compositions include a therapeutic agent and a relatively low amount of surfactant for providing higher bioavailability of the therapeutic agent. The compositions are particularly desirable as ophthalmic compositions in which the therapeutic agent is a prostaglandin such as travoprost and the surfactant is a vegetable oil such as castor oil. | 2009-09-17 |
20090234014 | Naphthalene-Disulfonamides Useful for the Treatment of Inflammation - There is provided compounds of formula (I), wherein R | 2009-09-17 |
20090234016 | COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS - Compounds useful for the treatment of various metabolic disorders, such as insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis are disclosed. wherein n is 1 or 2; m is 0, 1, 2, 3, 4 or 5; q is 0 or 1; t is 0 or 1; R | 2009-09-17 |
20090234019 | T Type Calcium Channel Inhibitors - The present invention provides novel T type calcium channel inhibitors of formula (I), the use thereof in the treatment of a disease or condition in a mammal associated with influx of extracellular calcium via T type calcium channels, | 2009-09-17 |
20090234041 | RADIATION CURABLE INK CONTAINING A CURABLE WAX - Curable monomer that is liquid at 25° C., curable wax and colorant together form a radiation curable ink. This ink may be used to form images by providing the radiation curable ink at a first temperature; applying the radiation curable ink to the substrate to form an image, the substrate being at a second temperature, which is below the first temperature; and exposing the radiation curable ink to radiation to cure the ink. | 2009-09-17 |
20090234045 | METHOD FOR MANUFACTURING POLYMER COMPOSITE - The disclosed is a method for manufacturing polymer composite in which a polymer as a dispersion medium and an additive to be added to the polymer is stirred for mixing in a cavity of a vessel to prepare a polymer composite in which the additive is dispersed in the polymer with a prescribed condition, wherein the stirring for mixing is performed under temperature conditions of not more than the softening temperature of the polymer until the additive is dispersed in the polymer with a prescribed condition, thereby the polymer is forced to lower the molecular weight thereof ephemerally by subjecting at least a part of chemical bonds in the polymer to cleavage, and thereafter the cleaved parts are rejoined. | 2009-09-17 |
20090234046 | Concrete and mortar admixture - The invention relates to a copolymer, said copolymer consisting of, as structural units, (i) 0.1 to 50 mole % of units derived from an ethylenically unsaturated monomer (a) having per one mole thereof 25 to 300 moles of C | 2009-09-17 |
20090234059 | MIKTOPOLYMER COMPOSITIONS - The present invention provides a block copolymer composition and method of making the same having the structures (A | 2009-09-17 |
20090234061 | Process for Producing a Fluororesin Sheet Containing a Filler and a Fluororesin Sheet Containing a Filler - A process for producing a fluororesin sheet containing a filler includes a step of rolling a sheet-forming resin composition including a fluororesin, a filler and a processing aid at a roll temperature of from 40 to 80° C. The processing aid includes at least 30% by mass of a petroleum hydrocarbon solvent having a fractionating temperature of not higher than 120° C. based on 100% by mass of the amount of the processing aid. The fluororesin sheet so produced provides high stress relaxation properties along with high hermetic sealing properties even when the content of the fluororesin is low and the content of the filler is high. | 2009-09-17 |
20090234062 | Aqueous emulsion polymer as dispersant - This invention relates to an aqueous emulsion polymer used as pigment dispersing agent comprising as copolymerized units the following monomers (A) an ethylenically unsaturated monomer containing at least one amino group; (B) an ethylenically unsaturated monomer containing no amino group; (C) optionally a hydroxy- or alkoxyalkyl(meth)acrylate of the formula CH | 2009-09-17 |
20090234063 | Aqueous Carbon Black Pigment and Aqueous Dispersion Thereof - An aqueous carbon black pigment that is suitable for an inkjet printer ink and the like and ensures that a printed article exhibits excellent water resistance and fixability, and an aqueous dispersion of the aqueous carbon black pigment are disclosed. The aqueous carbon black pigment includes oxidized carbon black, a water-soluble resin, and an aqueous medium, the oxidized carbon black and the water-soluble resin being crosslinked in the aqueous medium using a water-dispersible crosslinking agent. The water-soluble resin is preferably a resin that contains acrylic acid and/or an acrylic acid derivative as a monomer unit, a resin that contains a maleic acid and/or a maleic acid derivative as a monomer unit, a resin that contains a styrene-acrylic acid copolymer as a main component, a resin that contains a styrene-maleic acid copolymer or a styrene-maleic anhydride copolymer as a main component, or the like. The water-dispersible crosslinking agent is preferably an isocyanate compound. A carbon black aqueous dispersion includes the aqueous carbon black pigment and an aqueous medium, the aqueous carbon black pigment being dispersed in the aqueous medium at a concentration suitable for the desired application. | 2009-09-17 |
20090234064 | WATER-BASED RESIN COMPOSITION AND ARTICLES MADE THEREFROM - An aqueous elastomer dispersion includes a dispersed phase and an aqueous phase. The dispersed phase includes an elastomer including curable aliphatic conjugated-diene elastomers, such as polyisoprene, and a minor amount of at least one additive. The aqueous phase includes water and other optional components in either a soluble state or a dispersion state. The aqueous elastomer dispersion may be prepared by dissolving an elastomer, such as rubber, and additives in a solvent mixture and then converting the resulting solution into an aqueous emulsion. The aqueous emulsion is concentrated and the solvent is stripped from it to yield a dilute latex. The dilute latex that is obtained is concentrated again. Articles made from the aqueous elastomer dispersion include medical gloves, condoms, probe covers, dental dams, finger cots, catheters and the like. | 2009-09-17 |
20090234066 | Rubber composition for tire comprising an organosilicon coupling system - Tyre and rubber composition for tyre, based on at least one isoprene elastomer (for example natural rubber), an inorganic filler as reinforcing filler (for example silica) and a coupling system which provides the bonding between the said reinforcing inorganic filler and the isoprene elastomer, the said coupling system comprising, in combination:
| 2009-09-17 |
20090234068 | Polyarylene Sulfide and its Production Method - A polyarylene sulfide h as a narrow molecular weight distribution and a high molecular weight and high purity which is industrially useful, wherein the polyarylene sulfide has a weight average molecular weight of 10,000 or more, and weight loss when heated, ΔWr=(W | 2009-09-17 |
20090234069 | Oil-Based Ink Composition for Writing Instruments - An oil-based ink composition for writing instruments is provided that is capable of improving storage stability of an ink, while maintaining a leveling property even when a soluble gelling agent is used. The oil-based ink composition for writing instruments comprises a colorant, a resin, an organic solvent and a gelling agent, wherein said organic solvent(s) is (are) hydrocarbons solvent(s), and in particular, at least one species of the solvent selected from the group of aliphatic hydrocarbons solvent(s), alicyclic hydrocarbons solvent(s), aromatic hydrocarbons solvent(s), and halogenetad hydrocarbons solvent(s),
| 2009-09-17 |
20090234070 | Water-Soluble Polymer Alkanals - The present invention is directed to alkanal derivatives of water-soluble polymers such as poly(ethylene glycol), their corresponding hydrates and acetals, and to methods for preparing and using such polymer alkanals. The polymer alkanals of the invention are prepared in high purity and exhibit storage stability. | 2009-09-17 |
20090234073 | Alpha-Olefin/non-conjugated cyclic polyene copolymers, production processes thereof, and crosslinkable compositions including the copolymer - An α-olefin/non-conjugated cyclic polyene copolymer (A) includes structural units (I) derived from an α-olefin and structural units (H) derived from a vinyl group-containing cyclic olefin. The copolymer has a molecular weight distribution (Mw/Mn) of not more than 2.7 and is amorphous or low crystalline with a crystalline heat of fusion (ΔH) of less than 90 kJ/kg. The copolymer is efficiently produced using a specific transition metal catalyst that has a ligand with a phenoxyimine skeleton. The copolymer of the invention has a narrower molecular weight distribution and a higher content of vinyl groups as compared with existing copolymers. The copolymer can then give crosslinked products having excellent tensile properties. The copolymer is also used as a plasticizer for polymers such as rubbers, and provides excellent processability and superior mechanical strength and rubber elasticity of crosslinked products. By converting the vinyl groups in the copolymer to polar groups, various functional polyolefin materials are obtained. | 2009-09-17 |
20090234074 | WATER DISPERSIBLE RESIN, TWO-COMPONENT THERMOSETTING RESIN COMPOSITION, AND METHOD OF PRODUCING THE SAME - The water dispersible resin of the present invention is contained in a base component of a two-component thermosetting resin composition. The water dispersible resin is prepared by dispersing a solvent resin in water, which solvent resin is obtained by solution polymerization, carried out in two or more stages, of a monomer mixture containing a polyfunctional monomer, an acid group-containing monomer, and a hydroxyl group-containing monomer, the polyfunctional monomer having a plurality of vinyl groups in its single molecule. The monomer mixture contains the polyfunctional monomer by not less than 0.1% by weight but not more than 3% by weight, and the water dispersible resin thus obtained has an acid value of solid content of not less than 10 mgKOH/g but not more than 45 mgKOH/g, a hydroxyl value of solid content of not less than 50 but not more than 200, and a viscosity of not less than 50 mPa·s but not more than 10,000 mPa·s when a nonvolatile content is 45% by weight. This makes it possible to provide a two-component thermosetting resin composition, which is easily dealt with, formed into a coating film having an excellent appearance, and further, has an excellent pot life. | 2009-09-17 |
20090234075 | THERMOPLASTIC RESIN COMPOSITION AND MOLDED BODY - Provided is a thermoplastic resin composition having high impact resistance at low temperature and molded articles with good appearance using the thermoplastic resin composition. | 2009-09-17 |
20090234076 | PROPYLENE-BASED BLOCK COPOLYMER PARTICLES - Propylene-based block copolymer particles in accordance with the present invention are obtained by copolymerizing ethylene and propylene to form an ethylene-propylene copolymer in the presence of propylene polymer particles. The ratio of the intrinsic viscosity η | 2009-09-17 |
20090234080 | PROCESS FOR PRODUCING LATENT CATALYST AND EPOXY RESIN COMPOSITION - An object of the invention is to provide a preparation process of a latent catalyst that can gives a latent catalyst, which can exert an excellent catalytic activity at the time of molding and therefore, can provide a resin composition having good curing property, fluidity and storage stability, in a short time in a high yield without mixing in ionic impurities. The present invention relates to a preparation process of a phosphonium silicate latent catalyst, comprising reacting (A) a proton donor represented by the following formula (1): | 2009-09-17 |
20090234082 | Extrusion Coating Composition - The invention relates to an extrusion coating composition comprising an ethylene copolymer. | 2009-09-17 |
20090234083 | Polymerization Process for Preparing Polyolefins - A solution process for polymerizing one or more α-olefins of formula CH | 2009-09-17 |
20090234084 | Metallocene Compounds - A metallocene compound of formula (I) wherein M is zirconium titanium or hafnium; X is hydrogen, halogen or an hydrocarbon group; R | 2009-09-17 |
20090234085 | Nickel complexes in heterogeneous - The present invention discloses a supported catalyst system that comprises a supported Keim-type nickel complex. It further discloses a method for preparing said supported catalyst system and its use for homo- or co-polymerising polar and non polar monomers. | 2009-09-17 |
20090234086 | METHOD FOR PRODUCING FLUORINE-CONTAINING ELASTOMER - The present invention provides a method of producing a fluoroelastomer excellent in dispersion stability at low cost, at a high rate of polymerization and in high yields. | 2009-09-17 |
20090234093 | END REACTOR - The present invention relates to a reactor apparatus for free-flowing media, especially for polymers, for polycondensation of polyesters, comprising a rotor which rotates in a reactor casing having an inlet and outlet, said rotor being supported horizontally via a support apparatus by means of stub shaft arrangements which reach beyond the end walls of the reactor casing, wherein annular film-forming elements and, between the annular film-forming elements, strippers are arranged on the inner surfaces of the reactor casing on the rotor, such that the cylindrical rotor has at least one partly heated section. | 2009-09-17 |
20090234098 | METHOD OF PREPARING PEPTIDE - The present invention provides a method of preparing an intermediate for LHRH antagonists, which requires fewer steps than conventional methods and provides the intermediate in high yield and high purity. | 2009-09-17 |
20090234099 | Purification of Peptides from Colostrum - The invention relates to the purification of peptides from colostrum. The method involves the addition of an alcohol such as methanol or ethanol to the mixture in order to form an alcohol phase rich in the peptides, and a precipitate. The peptide-rich alcohol phase is subsequently recovered and subjected to further fractionation. The invention is particularly useful in the purification of colostrinin from colostrum. | 2009-09-17 |
20090234100 | OSTEOGENIC COMPOSITIONS COMPRISING AN AMIONO ACID SEQUENCE WHICH IS CAPABLE OF BEING PHOSPHORYLATED BY CAMK2 - Novel osteogenic compositions and methods are provided. In a broad aspect, the composition comprises either a first amino acid sequence which is capable of being phosphorylated by CAMK2; or a nucleic acid sequence encoding the first amino acid sequence; or a combination thereof. Optionally, the first amino acid sequence may further comprise a second amino acid sequence which is capable of binding the Smurf1 protein. Further, the composition may comprise a BMP protein and/or an agent capable of decreasing an amount or an activity of CAMK2. The compositions of the instant invention may be incorporated into an implant or delivered via a catheter. | 2009-09-17 |
20090234101 | DIRECTED EVOLUTION OF NOVEL BINDING PROTEINS - In order to obtain a novel binding protein against a chosen target, DNA molecules, each encoding a protein comprising one of a family of similar potential binding domains and a structural signal calling for the display of the protein on the outer surface of a chosen bacterial cell, bacterial spore or phage (genetic package) are introduced into a genetic package. The protein is expressed and the potential binding domain is displayed on the outer surface of the package. The cells or viruses bearing the binding domains which recognize the target molecule are isolated and amplified. The successful binding domains are then characterized. One or more of these successful binding domains is used as a model for the design of a new family of potential binding domains, and the process is repeated until a novel binding domain having a desired affinity for the target molecule is obtained. In one embodiment, the first family of potential binding domains is related to bovine pancreatic trypsin inhibitor, the genetic package is M13 phage, and the protein includes the outer surface transport signal of the M13 gene III protein. | 2009-09-17 |
20090234103 | NOVEL INHIBITORS OF VASCULAR ENDOTHELIAL GROWTH FACTOR ACTIVITY, THEIR USES AND PROCESSES FOR THEIR PRODUCTION - The present invention is directed to novel chimeric VEGF receptor proteins comprising amino acid sequences derived from the vascular endothelial growth factor (VEGF) receptors flt-1 and KDR, including the murine homologue to the human KDR receptor FLK-1, wherein said chimeric VEGF receptor proteins bind to VEGF and antagonize the endothelial cell proliferative and angiogenic activity thereof. The present invention is also directed to nucleic acids and expression vectors encoding these chimeric VEGF receptor proteins, host cells harboring such expression vectors, pharmaceutically acceptable compositions comprising such proteins, methods of preparing such proteins and to methods utilizing such proteins for the treatment of conditions associated with undesired vascularization. | 2009-09-17 |
20090234104 | Modified Fc molecules - The present invention concerns compositions of matter, for example, but not limited to, modified antibodies, in which one or more biologically active peptides are incorporated into a loop region of a non-terminal domain of an immunoglobulin Fc domain. | 2009-09-17 |
20090234105 | Construction of a Multivalent SCFV Through Alkyne-Azide 1,3-Dipolar Cycloaddition - The present invention provides for a practical, universal and efficient method to ligate two large macromolecules (e.g., proteins) using the alkyne-azide 1,3-dipolar cycloaddition reaction to produce a conjugated macromolecule, such as a multivalent scFv. The present invention also provides for conjugate macromolecules comprising a plurality of macromolecule components cross-linked through at least one linking group comprising at least one 1,2,3-triazole moiety, wherein at least 50 percent of the macromolecule components in the conjugate macromolecule has only one site available for cross-linking. | 2009-09-17 |
20090234106 | ANTI-ACTIVIN A ANTIBODIES AND USES THEREOF - The disclosure provides compositions and methods relating to or derived from anti-activin A binding proteins, including antibodies. In particular embodiments, the disclosure provides fully human, humanized, and chimeric anti-activin A antibodies that bind human activin A, activin A-binding fragments and derivatives of such antibodies, and activin A-binding polypeptides comprising such fragments. Other embodiments provide nucleic acids encoding such antibodies, antibody fragments and derivatives and polypeptides, cells comprising such polynucleotides, methods of making such antibodies, antibody fragments and derivatives and polypeptides, and methods of using such antibodies, antibody fragments and derivatives and polypeptides, including methods of treating or diagnosing subjects having activin A-related disorders or conditions including cachexia related to gonadal cancer, other cancers, rheumatoid arthritis, and other diseases. | 2009-09-17 |
20090234118 | Ionic Liquids - The present invention relates to compositions of matter that are ionic liquids, the compositions comprising any of eleven cations combined with any of three fluorinated sulfonated anions. Compositions of the invention should be useful as solvents and, perhaps, as catalysts for many reactions, including aromatic electrophilic substitution, nitration, acylation, esterification, etherification, oligomerization, transesterification, isomerization and hydration. | 2009-09-17 |
20090234119 | Ionic Liquids - The present invention relates to compositions of matter that are ionic liquids, the compositions comprising any of eleven cations combined with any of three fluorinated sulfonated anions. Compositions of the invention should be useful as solvents and, perhaps, as catalysts for many reactions, including aromatic electrophilic substitution, nitration, acylation, esterification, etherification, oligomerization, transesterification, isomerization and hydration. | 2009-09-17 |
20090234120 | Ionic Liquids - The present invention relates to compositions of matter that are ionic liquids, the compositions comprising any of eleven cations combined with any of three fluorinated sulfonated anions. Compositions of the invention should be useful as solvents and, perhaps, as catalysts for many reactions, including aromatic electrophilic substitution, nitration, acylation, esterification, etherification, oligomerization, transesterification, isomerization and hydration. | 2009-09-17 |
20090234122 | CYANINE DYE AND OPTICAL RECORDING MEDIUM - The present invention has an object to widen the range of applicable field of organic compounds to be selected as light absorbing materials in various fields including information recordings, solar energy generations, electric machinery apparatuses, electric communicating apparatuses, optical apparatuses, clothes, building/bedding/decorating products, sanitary and health goods, and agricultural materials, particularly, in the field of optical recording media by providing novel organic materials which absorb short-wavelength visible light, have improved lightfastness and solubility in solvents, and also have heat characteristics depending upon uses to be applied. The object is attained by providing cyanine dyes having a specific structure. | 2009-09-17 |
20090234123 | Processes For The Preparation Of Clopidogrel Hydrogen Sulfate Polymorphic Form I - Processes for the preparation of clopidogrel hydrogen sulfate of polymorphic form I are described which include use of specific solvents and process measures to avoid formation of undesired by-products. | 2009-09-17 |
20090234125 | Amorphous retapamulin and processes for preparation thereof - An amorphous form of Retapamulin, preferably in powder form, and processes for preparation thereof, are provided. Amorphous Retapamulin of the present invention can contain less than about 10 percent crystallinity, preferably less than about 5 percent crystallinity. Pharmaceutical compositions comprising amorphous Retapamulin are also provided. | 2009-09-17 |
20090234139 | Novel Process - A novel process for the preparation of 1′-hydroxy-2′-substituted cyclohexyl azetidin-2-one compound of formula 2, which is important intermediate in the synthesis of trinems, is described by epoxide ring opening of (3S,4R)-3-[(1R)-1-(tert-butyldimethylsilyloxy)ethyl]-4-[(1′R,2′S,3′R)-1′,2′-epoxycyclohexan-3′-yl]azetidin-2-one of formula 1 with the nucleophile compound of formula RYH, where nucleophile may act as solvent itself if the nucleophile is in the liquid form, in a suitable solvent and in the presence of a suitable catalyst from the group of salt of trifluoromethane sulfonic acid, preferably ytterbium (III) trifluoromethanesulfonate, stannous (II) trifluoromethanesulfonate or dysprosium (III) trifluoromethanesulfonate, under a) ultrasonic irradiation or b) under microwave irradiation of the reaction mixture following by isolation and purification of the desired compound. A variant of the novel process describes ring epoxide opening of the starting compound of formula 1 with the compound of formula NH | 2009-09-17 |
20090234140 | METHOD FOR SEPARATING OF OPTICALLY PURE THIOPHENE COMPOUNDS USING SIMULATED MOVING BED CHROMATOGRAPHY - Disclosed herein is a method of producing an optically active thiophene-based compound using a simulated moving bed adsorption separation process, and more specifically, a method of continuously separating a racemic thiophene-based compound into its optically active thiophene-based compounds having high purity, through optical resolution using the simulated moving bed process. According to the method of the current invention, a racemic mixture of a thiophene-based compound can be continuously separated into its optically active thiophene-based compounds having high purity, which is an intermediate of optically active dorzolamide acting as a topical therapeutic agent for glaucoma, using a simulated moving bed adsorption separation technique, thereby increasing industrial usability. | 2009-09-17 |
20090234142 | HIGH-YIELD CONVERSION OF CELLULOSIC BIOMASS INTO FURANIC BIOFUELS AND VALUE-ADDED PRODUCTS - Paper, cotton, corn stover, straw, and wood are converted into furanic products in high yields (based on their cellulose content) using a simple, inexpensive process involving concurrent hydrolysis, dehydration, and substitution reactions coupled with continuous extraction into an organic phase. In a simultaneous process, the hemicellulose fraction of these substrates is converted into furfural, and together these constitute an efficient means for the total exploitation of the carbohydrate content of biomass. | 2009-09-17 |
20090234144 | Reactor System and Process for the Manufacture of Ethylene Oxide - A reactor system for the epoxidation of ethylene, which reactor system comprises an elongated tube having an internal tube diameter of more than 40 mm, wherein contained is a catalyst bed of catalyst particles comprising silver and a promoter component deposited on a carrier, which promoter component comprises an element selected from rhenium, tungsten, molybdenum and chromium; a process for the epoxidation of ethylene comprising reacting ethylene with oxygen in the presence of the catalyst bed contained in the reactor system; and a method of preparing ethylene glycol, an ethylene glycol ether or an ethanol amine comprising obtaining ethylene oxide by the process for the epoxidation of ethylene, and converting the ethylene oxide into ethylene glycol, the ethylene glycol ether, or the ethanol amine. Preferably, the internal tube diameter is at least 45 mm. | 2009-09-17 |
20090234145 | METHOD AND CATALYSTS FOR THE EPOXIDATION OF OLEFINIC COMPOUNDS IN THE PRESENCE OF OXYGEN - The invention relates to a method for the epoxidation of an olefinic compound, which is characterised in that it comprises an oxidation reaction of at least one olefinic compound containing one or more double bonds C═C with oxygen in the presence of one or more reaction initiating agents, at least one catalyst containing at least one metal that is selected from a noble metal, a transition metal and mixtures of same, and at least one hydrocarbon that is selected from one or more branched alkanes, one or more alkyl cyclic or cyclic hydrocarbons, one or more alkyl aromatic or aromatic compounds and mixtures of same. | 2009-09-17 |
20090234147 | Light Protective Additive Based on Organic/Inorganic Hybrid Polymer, Method for Its Manufacture and Use thereof - Light protective additive based on a polybranched organic/inorganic hybrid polymer manufactured by a sol-gel process and method for its manufacture, having a chemical structure: | 2009-09-17 |
20090234158 | Catalyst for use in production of methacrylic acid and method for manufacturing the same - It is an object to provide a simple method for producing catalysts available in various reaction conditions, that allow gas-phase catalytic oxidation of methacrolein and the like to give methacrylic acid with high yield, high selectivity and stable methacrylic yield over extended time. | 2009-09-17 |
20090234161 | METHOD FOR THE PRODUCTION OF (METH)ACRYLIC ANHYDRIDE - The present invention relates to an improved method for manufacturing (meth)acrylic anhydride by transanhydrization between (meth)acrylic acid and acetic anhydride, in the presence of air and in the presence of at least one polymerization inhibitor, characterized in that the polymerization inhibitor is chosen from the group formed from (a) metal salts of thiocarbamic or dithiocarbamic acid and their mixtures with a phenolic derivative or phenothiazine and its derivatives, and (b) N-oxyl compounds as a mixture with 2,6-di-tert-butyl-4-methylphenol taken alone or in the presence of 2,4-dimethyl-6-tert-butylphenol. | 2009-09-17 |
20090234162 | Radioactive Halogen-Labeled Phenyloxyaniline Derivatives - A radioactive halogen-labeled phenyoxyaniline derivative represented by the following formula: wherein R | 2009-09-17 |
20090234163 | Method for producing an ethylamine - Processes comprising: (a) providing a first reactant comprising a bioethanol; and (b) reacting the first reactant with a second reactant comprising a component selected from the group consisting of ammonia, primary amines, secondary amines and mixtures thereof, in the presence of hydrogen and a catalytically effective amount of a heterogeneous hydrogenation/dehydrogenation catalyst to form an ethylamine; wherein the catalyst has been activated at a temperature of 100 to 500° C. for at least 25 minutes; wherein prior to activation the catalyst comprises: (i) 20 to 65% by weight of a support material comprising one or both of zirconium dioxide (ZrO | 2009-09-17 |
20090234164 | Oligomeric derivatives of spirobifluorene, their preparation and use - SBF derivatives, which can be represented with the following formula: SBF-X wherein: | 2009-09-17 |
20090234165 | PROCESS FOR THE MANUFACTURE OF FLUORINATED OLEFINS - A method for producing 1,1,1,2-tetrafluoropropene and/or 1,1,1,2,3 -pentafluoropropene using a single set of four unit operations, the unit operations being (1) hydrogenation of a starting material comprising hexafluoropropene and optionally recycled 1,1,1,2,3-pentafluoropropene; (2) separation of the desired intermediate hydrofluoroalkane, such as 1,1,1,2,3,3-hexafluoropropane and/or 1,1,1,2,3-pentafluoropropane; (3) dehydrofluorination of the intermediate hydrofluoroalkane to produce the desired 1,1,1,2-tetrafluoropropene and/or 1,1,1,2,3-pentafluoropropene, followed by another separation to isolate the desired product and, optionally, recycle of the 1,1,1,2,3-pentafluoropropene. | 2009-09-17 |
20090234166 | Hydroconversion process for petroleum resids by hydroconversion over carbon supported metal catalyst followed by selective membrane separation - A heavy residual petroleum feed boiling above 650° F.+ (345° C.+) is subjected to hydroconversion at elevated temperature in the presence of hydrogen at a hydrogen pressure not normally higher than 500 psig (3500 kPag) using a dispersed metal-on-carbon catalyst to produce a hydroconverted effluent which is fractionated to form a low boiling fraction and a relatively higher boiling fraction which is subjected to membrane separation to produce a permeate which is low in metals and Microcarbon Residue (MCR) as well as a retentate, containing most of the MCR and metals. The process has the advantage that the hydroconversion may be carried out in low pressure equipment with a low hydrogen consumption as saturation of aromatics is reduced. | 2009-09-17 |
20090234178 | SYSTEMS AND METHODS FOR DELIVERING RADIATION THERAPY - Described here are conformable brachytherapy applicators. The conformable brachytherapy applicators generally follow the contour of tissue surfaces so that distances between radiation sources and target tissues can be precisely determined and radiation dose clouds can be readily shaped. Systems and methods for using the conformable brachytherapy applicators are also described. | 2009-09-17 |
20090234179 | METHOD AND APPARATUS FOR MAGNETIC INDUCTION THERAPY - An energy emitting apparatus for providing a medical therapy includes one or more energy generators, a logic controller electrically connected to the one or more energy generators, and one or more sensors for detecting electric conduction in a target nerve that are connected to the logic controller. The one or more energy generators produce energy focused on the target nerve upon receiving a signal from the logic controller, and the energy is varied by the logic controller according to an input provided by the one or more sensors. In one embodiment, the energy emitting apparatus is an apparatus for magnetic induction therapy that includes one or more conductive coils disposed in an ergonomic housing that produce a magnetic field focused on the target nerve upon receiving an electric current from the logic controller based on an input provided by the one or more sensors. | 2009-09-17 |
20090234181 | Assessment Tool For Storing and Sharing Music Therapy Patient Records - This invention relates to an assessment tool for use in musical therapy comprising: (a) at least one patient record stored within the assessment tool; (b) at least one field or datum within the patient record; (c) a security scheme that either permits or denies authorization a user to view and/or edit each field or datum within each patient record; and optionally, (d) a plurality of users of the assessment tool each with a unique identification. This invention also relates to combining the above embodiments with a computer to store the patient records, and the security scheme. This above tool may also be connected to a network, including the internet, via the computer element. | 2009-09-17 |
20090234183 | ENDOSCOPE SYSTEM AND METHOD FOR INSPECTING ELECTRONIC ENDOSCOPE - An electronic endoscope has a light guide for leading a light and a solid-state image sensor for capturing an image of a human body cavity during illumination. In inspecting the number of broken optical fibers in the light guide, a cap is attached to a distal portion of the electronic endoscope. The cap has a test chart. The solid-state image sensor captures an image of the test chart which is illuminated with the light transmitted through the light guide. A photometric circuit calculates an average luminance value “Y” of the test chart from a chart image signal. A broken fiber number calculator calculates the number “N” of broken optical fibers that satisfies N=M×(1−Y/I). “Y” represents an average luminance value of the test chart. “I” represents an ideal average luminance value when all optical fibers are conducting, and “M” represents the total number of the optical fibers. | 2009-09-17 |
20090234184 | ENDOSCOPE - An endoscope comprises: an insertion tube to be inserted into a body cavity, the insertion tube including a hard distal end portion, a curving portion continuous with the hard distal end portion, and a flexible portion continuous with the curving portion; a contained part of the insertion tube which is accommodated at least inside the curving portion; and at least one movement regulating member which extends inside the curving portion and adapted to regulate at least radial movement of the contained part, one end portion of the position regulating member passing through a rear connecting portion connecting the curving portion and the flexible portion to extend to the flexible portion side, a section of a portion of the movement regulating member inserted into the flexible portion from the rear connecting portion being smaller than a section of a portion of the movement regulating member within the curving portion. | 2009-09-17 |
20090234186 | Gastrointestinal endoscope with deflectable direction-change structure and deflectable direction-change tube thereof - Disclosed is a gastrointestinal endoscope, including a deflectable direction-change tube, which consists of plural ring units, each having a hollow section. Adjacent ring units are spaced by a predetermined distance, having opposing end faces between which at least two integrally formed connectors are provided to connect the adjacent ring units together. An end of the deflectable direction-change tube is operatively coupled to a direction-change operation device and an opposite end coupled to a capsule endoscope clamping structure. At least one control wire extends through a bore of the deflectable direction-change tube and connected between the direction-change operation device and the capsule endoscope clamping structure. By operating an operation capstan to have the control wire pulling the capsule endoscope clamping structure, the deflectable direction-change tube is controlled to change direction, thereby changing direction of a capsule endoscope retained by the capsule endoscope clamping structure. | 2009-09-17 |
20090234198 | HEALTHCARE KNOWLEDGEBASE - A method is provided for automatically retrieving information from a computerized healthcare knowledgebase. The method involves collecting data about a user from one or more biometric sensors, analyzing the data to determine a condition of the user, processing the user condition information to formulate a query of the computerized healthcare knowledgebase for relevant content, and presenting the relevant content to the user in an automated fashion. The healthcare knowledgebase includes a plurality of records having a reference to healthcare related multimedia content and numeric biometric limit parameters indicating one or more physiological conditions to which the referenced content is relevant. The numeric biometric limit parameters may include rolling statistical information that is updated periodically based on data collected from a plurality of users over time. | 2009-09-17 |
20090234199 | BLOOD PRESSURE MEASURING APPARATUS - A control unit ( | 2009-09-17 |
20090234200 | In-Situ Measurement of Physical Parameters - A data logger device for in-situ measurement of one or more physical parameters comprising a power source; one or more sensors for measuring the one or more physical parameters; a data store for storing representations of at least some of the measured values of the one or more physical parameters; control logic arranged to write the representations of at least some of the measured values to the data store and arranged to read data from the data store during data transmission; an antenna; and a transmitter coupled to the antenna and configured to transmit the stored data by passive transmission. | 2009-09-17 |
20090234203 | CAPSULE FOR MEDICAL USE - A capsule for medical use which is to be passed through a tract of a human or animal body includes a capsule-shape case, a wire antenna placed in a wrapped or folded state on at least a portion of an outer surface of the case, and a fixing member configured to fix the wire antenna in the wrapped or folded state, wherein the fixing member is configured to release the antenna inside the tract. | 2009-09-17 |
20090234204 | Methods for Noninvasive Determination of in vivo Alcohol Concentration using Raman Spectroscopy - Methods and apparatuses for the determination of an attribute of the tissue of an individual use non-invasive Raman spectroscopy. For example, the alcohol concentration in the blood or tissue of an individual can be determined non-invasively. A portion of the tissue is illuminated with light, the light propagates into the tissue where it is Raman scattered within the tissue. The Raman scattered light is then detected and can be combined with a model relating Raman spectra to alcohol concentration in order to determine the alcohol concentration in the blood or tissue of the individual. Correction techniques can be used to reduce determination errors due to detection of light other than that from Raman scattering from the alcohol in the tissue. Other biologic information can be used in combination with the Raman spectral properties to aid in the determination of alcohol concentration, for example age of the individual, height of the individual, weight of the individual, medical history of the individual and his/her family, ethnicity, skin melanin content, or a combination thereof. The method and apparatus can be highly optimized to provide reproducible and, preferably, uniform radiance of the tissue, low tissue sampling error, depth targeting of the tissue layers or sample locations that contain the attribute of interest, efficient collection of Raman spectra from the tissue, high optical throughput, high photometric accuracy, large dynamic range, excellent thermal stability, effective calibration maintenance, effective calibration transfer, built-in quality control, and ease-of-use. | 2009-09-17 |
20090234205 | METHOD AND APPARATUS FOR KIDNEY FUNCTION ANALYSIS - A method and apparatus for determining physiological data related to an animal, such as kidney diagnostics data, is provided. The method includes injecting a mixture of a first and a second molecule into an animal (e.g., a human patient), determining a molecular ratio of the molecules, and determining the physiological data based on the molecular ratio. The apparatus includes a number of finger receiving apertures, a light generation circuit, a light detection circuit, a pulse counting circuit, and a user interface. | 2009-09-17 |
20090234206 | MEDICAL DEVICE FOR DIAGNOSING PRESSURE ULCERS - Medical device or instrument for diagnosing pressure ulcers using optical reflectance spectroscopy. The device may comprise a tip and a controller. The tip is pressed against the skin of the patient and collects the optical reflectance data. The controller processes the data to determine whether there exists a pressure ulcer and, if there is one, its depth. The tip may also include a pressure sensor for sensing the pressure at which the tip is applied to the patient's skin. | 2009-09-17 |
20090234219 | Particle Radiation Therapy Equipment - Particle radiation therapy equipment arranged to apply a charged particle beam to a region of application in a predetermined direction, comprising a charged particle beam source arranged to direct a charged particle beam in the predetermined direction, further comprising magnetic field generation means for generating a magnetic field in an imaging volume which includes the region of application at the same time that the charged particle beam is applied, wherein the magnetic field generation means is arranged to provide access to the region of application for the charged particle beam, and to provide a homogeneous magnetic field in the region of application of the charged particle beam, said magnetic field being directed substantially in the predetermined direction. | 2009-09-17 |
20090234220 | Catheter and associated medical examination and treatment device - A catheter for treatment of the heart with a flexible catheter sheath surrounding a catheter lumen and with an apparatus for implanting cell material, which comprises an injection apparatus arranged in an area of the catheter tip, is to be created such that the risk of such an intervention is reduced in relation to previously known and practiced concepts. To this end there is inventive provision for at least one imaging sensor to be arranged in the area of the catheter tip. | 2009-09-17 |
20090234221 | RESPONSIVE PARAMAGNETIC MRI CONTRAST AGENTS - A method is claimed based on CEST procedure for the in vivo or in vitro determination of physical or chemical parameters which includes the use of a responsive paramagnetic CEST contrast agent. | 2009-09-17 |
20090234222 | System for magnetic resonance imaging assisted surgery - A system and method for magnetic resonance imaging assisted surgery. The system includes an antenna support assembly and an antenna that are used to acquire real time images of the surgical site that may be used by a surgeon to more accurately perform the surgical procedure. The method comprises acquiring real time images of the surgical site and feeding back the images to a surgeon performing the surgical procedure. | 2009-09-17 |
20090234223 | Surgery Assisting Apparatus and Treatment Assisting Apparatus - According to the invention, an endoscope system as a surgery assisting apparatus includes a surgery apparatus for performing treatment by abdominal operation procedure on a region to be treated in a body of a patient, and a luminal organ shape detecting apparatus used for assisting (supporting) the abdominal operation procedure. The luminal organ shape detecting apparatus is used as blood vessel position notifying means when procedure is performed by inserting a probe as a luminal organ insertion probe into a blood vessel, for example. This allows the luminal organ irrespective of the treatment to be easily and surely detected and enables a smooth procedure to be performed. | 2009-09-17 |
20090234225 | FLUORESCENCE DETECTION SYSTEM - Exemplary embodiments include systems, methods, and compositions for the intra-operative detection of target tissue. At least one embodiment includes a fluorescence detection instrument that may be used for intra-operative detection of a fluorescent targeting agent, its binding site, and its interaction within cancer tissues. An exemplary embodiment is highly sensitive to the local deposition of fluorescence agents even at a low concentration. In at least one embodiment, the system includes a handheld navigation instrument that is usable to excite, detect, and report the fluorescent deposition of the targeting agent in real-time. In alternative embodiments, the system includes a wearable unit to excite, detect, and visually report the fluorescent deposition of the targeting agent to the user. The wearable unit includes eyewear that allow the user to perform image-guided surgery based on the near real-time fluorescence detection of the fluorescent targeting agent. | 2009-09-17 |
20090234226 | CHEMICAL LIQUID INJECTOR - The injector ( | 2009-09-17 |
20090234239 | Analysis of electrocardiogram signals - Apparatus for graphical representation of a train of ECG complexes, said ECG complexes comprising an R wave and a T-P interval and having variable isoelectric levels, the apparatus comprising: an isoelectric alignment unit for aligning the complexes in terms of isoelectric level by aligning respective T-P intervals, thereby to provide a graphical representation of said train of ECG complexes; and a temporal alignment unit for aligning said complexes temporally using a predetermined point of respective R waves. The aligned units are superimposed to provide a distribution of a normalized ECG signal over a series of pulses or heartbeats. | 2009-09-17 |
20090234240 | Respiration as a Trigger for Therapy Optimization - Changes in patient status are assessed based at least in part on respiration parameters. A user can make selections regarding alert criteria options to be used in assessing patient status. Respiration is implantably sensed and respiration data is stored by an implantable device. A respiration parameter, such as respiration rate, is measured from the respiration data. The change in patient status is assessed by comparing the respiration parameter to the configured alert criteria. If the comparison of the respiration parameter and the configured alert criteria indicates a significant change in patient status, an alert signal is generated. | 2009-09-17 |
20090234241 | RECORDING MEDIUM, DEVICE, AND METHOD FOR SLEEP APNEA DETECTION - A device for sleep apnea detection, includes an external sound recorder that records external sound in environment, a sound/silence determining unit that determines whether an audible sound or no sound is found in the external sound recorded in the external sound recorder, a breathing pace analyzing unit that analyzes, using information of intervals of the audible sound and no sound found by the sound/silence determining unit and the external sound, a breathing pace indicating a cycle of a breathing estimated interval during which breathing is estimated, and an apnea interval extracting unit that extracts a silent interval within the breathing estimated interval based on the breathing pace analyzed by the breathing pace analyzing unit. | 2009-09-17 |
20090234242 | Multi-Channel EEG Electrode System - A device comprises an indicating unit configured to indicate information and a connecting unit configured to connect the indicating unit to an electrode operable to sense an EEG signal, such that the information is indicated at a position at which the electrode is placed. | 2009-09-17 |
20090234243 | ROBOTIC APPARATUS FOR TARGETING AND PRODUCING DEEP, FOCUSED TRANSCRANIAL MAGNETIC STIMULATION - Techniques for applying electromagnetic energy to deep, targeted areas without overwhelming other areas are provided. One or more coils are moved relative to a target area and magnetic fields are applied to the target from multiple coil locations. As a result, the aggregate electromagetic energy applied to the target over time is greater than surrounding areas. Additionally, a model for testing and treatment planning is provided. | 2009-09-17 |
20090234244 | Data collection for electrical impedance tomography - The invention refers to a method for carrying out data collection on electrodes placed on a body for subsequent processing of an electrical impedance tomography image of a corresponding part of said body. In order to improve the resolution of electrical impedance tomography systems without noticeably affecting the signal-to-noise ratio, the method according to the invention comprises the steps of placing the electrodes on a peripheral line around the body, applying a current pattern from a current source to at least one pair of electrodes, and measuring differential potentials between pairs of electrodes, wherein at least one intermediate electrode lies in between each pair of electrodes for measuring the differential potentials and the differential potentials of one current pattern for the subsequent image processing refer to at least three different pairs of electrodes with no electrode used more than twice for each current pattern. | 2009-09-17 |
20090234245 | NON-INVASIVE MONITORING OF INTRACRANIAL PRESSURE - Methods, systems, and related computer program products for are described for non-invasive detection of intracranial pressure (ICP) variations in an intracranial compartment of a patient. Optical radiation is propagated transcranially into the intracranial compartment, and optical radiation that has migrated through at least a portion of the intracranial compartment and back out of the cranium is detected. At least one signal representative of the detected optical radiation is processed to extract therefrom at least one component signal that varies in time according to at least one of an intrinsic physiological oscillation and an externally driven oscillation in the patient. Examples of suitable intrinsic physiological oscillations include intrinsic respiratory and cardiac oscillations. Examples of suitable externally driven oscillations include ventilated respiratory oscillations and externally mechanically induced oscillations. The extracted component signal is then processed to generate an output signal representative of the ICP variations in the intracranial compartment. | 2009-09-17 |
20090234246 | BODY FLUID SAMPLER AND METHOD THEREFOR - To provide a body fluid sampling method and its device capable of sampling a minimum necessary amount of blood without loss while reducing a burden on a subject to the minimum. The skin surface of a sampling site is made water repellent. A skin surface thus made water repellent is pierced. A body fluid held in a droplet shape on the pierced skin surface is then collected. | 2009-09-17 |
20090234247 | Medical Appliance Having Polyimide Film and Method for Manufacture Thereof - Provided is a medical appliance excellent in slidability and durability. A medical appliance comprising a base material, a polyimide film (A) and a polymer film (B) having a higher nitrogen content and/or a higher oxygen content than respective contents of the polyimide film (A). The appliance has the polymer film (B) on a part or the whole of the surface of the base material, and has the polyimide film (A) on the polymer film (B). | 2009-09-17 |
20090234258 | Leg ulcer, lymphoedema and DVT vibratory treatment and device - An ulcer, lymphoedema and DVT treatment device ( | 2009-09-17 |